In the early phase of cancer development, neutrophils exert anticancer activity by reactive oxygen species (ROS) that cause tumour cell lysis and by the production of co-stimulatory molecules that enhance the proliferation of CD4+ and CD8+ T lymphocytes. This evidence concerns the gene CD8A and neoplasm.